Volume 24, Number 10—October 2018
Research
Rapid Increase in Carriage Rates of Enterobacteriaceae Producing Extended-Spectrum β-Lactamases in Healthy Preschool Children, Sweden
Johan Kaarme
, Hilde Riedel, Wesley Schaal, Hong Yin, Tryggve Nevéus, and Åsa Melhus
, Hilde Riedel, Wesley Schaal, Hong Yin, Tryggve Nevéus, and Åsa Melhus
Table.
| Drug |
DDD/1,000 person-days |
| Phenoxymethylpenicillin | 2.44 |
| Amoxicillin | 0.59 |
| Flucloxacillin | 0.56 |
| Amoxicillin/clavulanic acid | 0.20 |
| Trimethoprim/sulfamethoxazole | 0.18 |
| Cefadroxil | 0.16 |
| Erythromycin | 0.13 |
| Pivmecillinam | 0.08 |
| Clindamycin | 0.06 |
| Ceftibuten | 0.06 |
| Nitrofurantoin | 0.05 |
| Azithromycin | 0.05 |
| Ciprofloxacin | 0.05 |
| Cloxacillin | 0.03 |
| Meropenem | 0.02 |
| Cefotaxime | 0.02 |
| Metronidazole | 0.02 |
| Benzylpenicillin | 0.01 |
| Vancomycin | 0.01 |
| Piperacillin/tazobactam | 0.01 |
*The following drugs had DDD values <0.01/1,000 person-days: coxycycline, ampicillin, cefuroxime, ceftazidime, ceftriaxone, ertapenem, imipenem, ceftaroline fosamil, tobramycin, gentamicin, moxifloxacin, colistin, daptomycin, rifampin, retapamulin, and fusidic acid. DDD, defined daily dose.
Page created: September 14, 2018
Page updated: September 14, 2018
Page reviewed: September 14, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.